Research lines about Inflamatory Bowel Disease

Although the vast majority of patients with inflammatory bowel disease can be treated adequately with current medicines, some patients need to receive treatments in the research phase (clinical trials) due to a loss or lack of response to approved treatments. 

There are currently several clinical trials being carried out on new drugs which have different therapeutic targets to those already available with favorable preliminary results.

Another possibility, for severe cases of Crohn’s disease that neither respond to medical treatment nor are they prone to surgery, are autologous haematopoietic progenitor transplants (autotransplants). This procedure has also demonstrated its efficacy in very specific cases of severe Crohn’s disease. However, as it is associated with a high risk of complications (primarily potentially lethal infections), it can only be performed in specialised and experienced centres where there is close collaboration between the haematological and gastroenterological teams.

For more information:

• http://blog.hospitalclinic.org/en/2009/02/stem-cells-to-treat-crohns-disease/
• http://blog.hospitalclinic.org/es/2016/07/la-terapia-celular-es-eficaz-para-tratar-las-fistulas-en-la-enfermedad-de-crohn-y-evitar-el-quirofano/